An update of clinical management of acute intermittent porphyria

References

• AndersonKESassaSBishopDFDesnickRJDisorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyriasScriverCRBeaudetASlyWSValleDThe Metabolic and Molecular Bases of Inherited Disease28th edNew YorkMcGraw-Hill200129913062
   Google Scholar
• KauppinenRPorphyriasLancet200536524125215652607
   PubMed Web of Science ®Google Scholar
• BonkovskyHLMaddukuriVCYaziciCAcute porphyrias in the USA: ceatures of 108 subjects from porphyrias consortiumAm J Med2014127121233124125016127
   PubMed Web of Science ®Google Scholar
• KuhnelAGrossUDossMOHereditary coproporphyria in Germany: clinical-biochemical studies in 53 patientsClin Biochem200033646547311074238
   PubMed Web of Science ®Google Scholar
• von und zu FraunbergMTimonenKMustajokiPKauppinenRClinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patientsEur J Hum Gen200210649657
   Web of Science ®Google Scholar
• MustajokiPNordmannYEarly administration of Heme Arginate for acute porphyric attacksArch Int Med199315317200420088357285
   PubMedGoogle Scholar
• SardhEHarperPAnderssonDEFloderusYPlasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacksEur J Int Med2009202201207
   Web of Science ®Google Scholar
• KauppinenRMustajokiPPrognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseasesMedicine19927111131549056
   PubMed Web of Science ®Google Scholar
• JeansJBSavikKGrossCRMortality in patients with acute intermittent porphyria requiring hospitalization: a United States case seriesAm J Med Genet19966542692738923933
   PubMed Web of Science ®Google Scholar
• PischikEBulyanitsaAKazakovVKauppinenRClinical features predictive of a poor prognosis in acute porphyriaJ Neurol2004251121538154115645362
   PubMed Web of Science ®Google Scholar
• HiftRJMeissnerPNAn analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severityMedicine (Baltimore)2005841486015643299
   PubMed Web of Science ®Google Scholar
• von und zu FraunbergMPischikEUddLKauppinenRClinical and biochemical characteristics and genotype-phenotype correlation in 143 Finnish and Russian patients with acute intermittent porphyriaMedicine (Baltimore)2005841354715643298
   PubMed Web of Science ®Google Scholar
• SardhEWahlinSBjornstedtMHarperPAnderssonDEHigh risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic PorphyriaJ Inherit Metab Dis20133661063107123344888
   PubMed Web of Science ®Google Scholar
• InnalaEAnderssonCScreening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern SwedenJ Int Med20112695538545
   Web of Science ®Google Scholar
• StewartMFReview of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-upJ Clin Pathol2012651197698022851509
   PubMed Web of Science ®Google Scholar
• PischikEKauppinenRNeurological manifestations of acute intermittent porphyriaCell Mol Biol (Noisy-le-grand)2009551728319268005
   PubMed Web of Science ®Google Scholar
• AnderssonCInnalaEBackstromTAcute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones. A population-based study in northern SwedenJ Int Med20032542176183
   Web of Science ®Google Scholar
• FraserDJPodvinecMKaufmannMRMeyerUADrugs mediate the transcriptional activation of the 5-aminolevulinic acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear receptor (CXR)J Biol Chem200227738347173472612121995
   PubMed Web of Science ®Google Scholar
• MeyerUASchuurmansMMLindbergRLAcute porphyrias: pathogenesis of neurological manifestationsSemin Liver Dis199818143529516677
   PubMed Web of Science ®Google Scholar
• BrennanMJCantrillRCDelta-Aminolaevulinic acid and amino acid neurotransmittersMol Cell Biochem198138Pt 149586117007
   PubMed Web of Science ®Google Scholar
• PischikEKauppinenRPotential role of oxidative damage in neurological manifestations of acute intermittent porphyriaGadothNGöbelHHOxidative Stress and Free Radical Damage in NeurologyVIIITotowa, NJHumana Press2011293311
   Google Scholar
• HandschinCLinJRheeJNutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alphaCell2005122450551516122419
   PubMed Web of Science ®Google Scholar
• SardhERejkjaerLAnderssonDEHarperPSafety, pharmacokinetics and pharmocodynamics of recombinant human porphobilinogen deaminase in healthy subjects and asymptomatic carriers of the acute intermittent porphyria gene who have increased porphyrin precursor excretionClin Pharmacokinet200746433534917375984
   PubMed Web of Science ®Google Scholar
• SingalAKParkerCBowdenCThaparMLiuLMcGuireBMLiver transplantation in the management of porphyriaHepatology20146031082108924700519
   PubMed Web of Science ®Google Scholar
• MarsdenJTReesDCA retrospective analysis of outcome of pregnancy in patients with acute porphyriaJ Inh Metab Dis2010335591596
   Web of Science ®Google Scholar
• RifkindABGillettePNSongCSKappasAInduction of hepatic delta-amino-levulinic acid synthetase by oral contraceptive steroidsJ Clin Endocrinol Metab19703033303354189570
   PubMed Web of Science ®Google Scholar
• PischikEKauppinenRCan pregnancy stop cyclical attacks of porphyria?Am J Med20061191889016431203
   PubMed Web of Science ®Google Scholar
• InnalaEBackstromTPoromaaISAnderssonCBixoMWomen with acute intermittent porphyria have a defect in 5alpha-steroid production during the menstrual cycleActa Obstet Gynecol Scand201291121445145222924787
   PubMed Web of Science ®Google Scholar
• ChristianCAMoenterSMThe neurobiology of preovulatory and estradiol-induced gonadotropin-releasing hormone surgesEndocr Rev201031454457720237240
   PubMed Web of Science ®Google Scholar
• KalsbeekALa FleurSVan HeijningenCBuijsRMSuprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liverJ Neurosci200424357604761315342726
   PubMed Web of Science ®Google Scholar
• BonkovskyHLBarnardGFDiagnosis of porphyric syndromes: a practical approach in the era of molecular biologySemin Liver Dis199818157659516679
   PubMed Web of Science ®Google Scholar
• DeaconACElderGHACP Best Practice No 165: front line tests for the investigation of suspected porphyriaJ Clin Pathol200154750050711429419
   PubMed Web of Science ®Google Scholar
• ThunellSHarperPBrockAPetersenNEPorphyrins, porphyrin metabolism and porphyrias. II. Diagnosis and monitoring in the acute porphyriasScand J Clin Lab Invest200060754155911202049
   PubMed Web of Science ®Google Scholar
• KauppinenRvon und zu FraunbergMMolecular and biochemical studies of acute intermittent porphyria in 1 96 patients and their familiesClin Chem200248111891190012406973
   PubMed Web of Science ®Google Scholar
• DaniellWEStockbridgeHLLabbeRFEnvironmental chemical exposures and disturbances of heme synthesisEnviron Health Perspect1997105Suppl 137539114276
   PubMedGoogle Scholar
• PischikEKazakovVKauppinenRIs screening for urinary porphobilinogen useful among patients with acute polyneuropathy or encephalopathy?J Neurol2008255797497918574620
   PubMed Web of Science ®Google Scholar
• MooreMRMcCollKERimingtonCGoldbergADisorders of Porphyrin MetabolismNew YorkPlenum Publishing Corporation1987
   Google Scholar
• Poh-FitzpatrickMBLamolaAADirect spectrofluorometry of diluted erythrocytes and plasma: a rapid diagnostic method in primary and secondary porphyrinemiasJ Lab Clin Med19768723623701245797
   PubMed Web of Science ®Google Scholar
• WhatleySDRobertsAGLlewellynDHBennettCPGarrettCElderGHNon-erythroid form of acute intermittent porphyria caused by promoter and frameshift mutations distant from the coding sequence of exon 1 of the HMBS geneHum Genet2000107324324811071386
   PubMed Web of Science ®Google Scholar
• GrandchampBPicatCMignotteVTissue-specific splicing mutation in acute intermittent porphyriaProc Natl Acad Sci USA19898626616642563167
   PubMed Web of Science ®Google Scholar
• KostrzewskaEGregorAIncreased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyriaAnn Clin Res19861841951983789651
   PubMedGoogle Scholar
• KauppinenRMolecular diagnostics of acute intermittent porphyriaExp Rev Mol Diag200442243249
   PubMed Web of Science ®Google Scholar
• PuyHDeybachJCLamorilJMolecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyriaAm J Hum Genet1997606137313839199558
   PubMed Web of Science ®Google Scholar
• WhatleySDWoolfJRElderGHComparison of complementary and genomic DNA sequencing for the detection of mutations in the HMBS gene in British patients with acute intermittent porphyria: identification of 25 novel mutationsHum Genet1999104650551010453740
   PubMed Web of Science ®Google Scholar
• The Human Gene Mutation Database [database on the Internet]Cardiff, UKInstitute of Medical Genetics in Cardiff, Cardiff University Available from: http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HMBSAccessed June 13, 2015
   Google Scholar
• BylesjoIWikbergAAnderssonCClinical aspects of acute intermittent porphyria in northern Sweden: a population-based studyScand J Clin Lab Invest200969561261819401933
   PubMed Web of Science ®Google Scholar
• ElderGHarperPBadmintonMSandbergSDeybachJCThe incidence of inherited porphyrias in EuropeJ Inh Metab Dis2013365849857
   PubMed Web of Science ®Google Scholar
• AndersonKECollinsSOpen-label study of hemin for acute porphyria: clinical practice implicationsAm J Med20061199801.e819e82416945618
   PubMed Web of Science ®Google Scholar
• SteinPBadmintonMBarthJReesDStewartMFBest practice guidelines on clinical management of acute attacks of porphyria and their complicationsAnn Clin Biochem201350Pt 321722323605132
   PubMed Web of Science ®Google Scholar
• GoldbergAAcute intermittent porphyria. A study of 50 casesQ J Med19592818320913658350
   PubMedGoogle Scholar
• RidleyABThe neuropathy of acute intermittent porphyriaQ J Med1969381513073335343605
   PubMedGoogle Scholar
• SteinJATschudyDPAcute intermittent porphyria: a clinical and biochemical study of 46 patientsMedicine19704911164907358
   PubMed Web of Science ®Google Scholar
• MustajokiPKoskeloPHereditary hepatic porphyrias in FinlandActa Med Scand19762003171178970225
   PubMedGoogle Scholar
• HerrickALMcCollKEMooreMRCookAGoldbergAControlled trial of haem arginate in acute hepatic porphyriaLancet198918650129512972566827
   PubMed Web of Science ®Google Scholar
• AndersonKEBonkovskyHLBloomerJRShedlofskySIReconstitution of hematin for intravenous infusionAnn Int Med2006144753753816585674
   PubMed Web of Science ®Google Scholar
• SimionattoCSCabalRJonesRLGalbraithRAThrombophlebitis and disturbed hemostasis following administration of intravenous hematin in normal volunteersAm J Med19888545385403177402
   PubMed Web of Science ®Google Scholar
• DaimonMSusaIgarashiMKatoTKamedaWAdministration of heme arginate, but not hematin, caused anaphylactic shockAm J Med2001110324011221635
   PubMed Web of Science ®Google Scholar
• TschudyDPWellandFHCollinsAThe effect of carbohydrate feeding on the induction of delta-aminolevulinic acid synthetaseMetabolism19641339640614169218
   PubMed Web of Science ®Google Scholar
• AndersonKEBloomerJRBonkovskyHLRecommendations for the diagnosis and treatment of the acute porphyriasAnn Int Med2005142643945015767622
   PubMed Web of Science ®Google Scholar
• ElderGHHiftRJTreatment of acute porphyriaHosp Med200162742242511480131
   PubMed Web of Science ®Google Scholar
• YrjonenAPischikEMehtalaSKauppinenRA novel 19-bp deletion of exon 15 in the HMBS gene causing acute intermittent porphyria associating with rhabdomyolysis during an acute attackClin Genet200874439639818647325
   PubMed Web of Science ®Google Scholar
• SusaSDaimonMMoritaYAcute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosisNeuroradiology1999411183583910602858
   PubMed Web of Science ®Google Scholar
• MarsdenJTChowdhuryPWangJAcute intermittent porphyria and chronic renal failureClin Nephrol200869533934618538096
   PubMed Web of Science ®Google Scholar
• Porphyria South Africa [homepage on the Internet] Available from: http://www.porphyria.uct.ac.za/Accessed June 13, 2015
   Google Scholar
• Epnet-European Porphyria Network [homepage on the Internet] Available from: http://www.porphyria-europe.comAccessed June 13, 2015
   Google Scholar
• The Drug Database for Acute Porphyria [homepage on the Internet] Available from: http://www.drugs-porphyria.orgAccessed June 13, 2015
   Google Scholar
• American Porphyria Foundation [homepage on the Internet] Available from: http://www.porphyriafoundation.com/drug-databaseAccessed June 13, 2015
   Google Scholar
• JensenMPKarolyPSelf-report scales and procedures for assessing pain in adultsMelzackRHandbook of Pain AssessmentNew YorkGuildford Press1992135151
   Google Scholar
• MuiesanMLSalvettiMAmadoroVAn update on hypertensive emergencies and urgenciesJ Cardiovasc Med (Hagerstown)201516537238225575271
   PubMed Web of Science ®Google Scholar
• ShenhavSGemerOSassoonESegalSAcute intermittent porphyria precipitated by hyperemesis and metoclopramide treatment in pregnancyActa Obstet Gynecol Scand19977654844859197454
   PubMed Web of Science ®Google Scholar
• GrossUHoncampMDaumeEFrankMDusterbergBDossMOHormonal oral contraceptives, urinary porphyrin excretion and porphyriasHorm Metab Res19952783793837590628
   PubMed Web of Science ®Google Scholar
• De BlockCELeeuwIHGaalLFPremenstrual attacks of acute intermittent porphyria: hormonal and metabolic aspects – a case reportEur J Endocrinol19991411505410407223
   PubMed Web of Science ®Google Scholar
• HerrickALMcCollKEWallaceAMMooreMRGoldbergALHRH analogue treatment for the prevention of premenstrual attacks of acute porphyriaQ J Med1990752763553632117297
   PubMedGoogle Scholar
• InnalaEBackstromTBixoMAnderssonCEvaluation of gonadotropin-releasing hormone agonist treatment for prevention of menstrual-related attacks in acute porphyriaActa Obstet Gynecol Scand20108919510020021268
   PubMed Web of Science ®Google Scholar
• AndersonKESpitzIMBardinCWKappasAA gonadotropin releasing hormone analogue prevents cyclical attacks of porphyriaArch Int Med19901507146914742196028
   PubMedGoogle Scholar
• DowmanJKGunsonBKMirzaDFBramhallSRBadmintonMNNewsomePNLiver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosisLiver Transplant2012182195200
   PubMed Web of Science ®Google Scholar
• DowmanJKGunsonBKBramhallSBadmintonMNNewsomePNLiver transplantation from donors with acute intermittent porphyriaAnn Int Med2011154857157221502660
   PubMed Web of Science ®Google Scholar
• BadmintonMNDeybachJCTreatment of an acute attack of porphyria during pregnancyEur J Neurol200613666866916796597
   PubMed Web of Science ®Google Scholar
• ChurchSEMcCollKEMooreMRYoungsGRHypertension and renal impairment as complications of acute porphyriaNephrol Dial Transplant19927109869901331893
   PubMed Web of Science ®Google Scholar
• AnderssonCLithnerFHypertension and renal disease in patients with acute intermittent porphyriaJ Int Med19942362169175
   Web of Science ®Google Scholar
• SardhEAnderssonDEHenrichsonAHarperPPorphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimesCell Mol Biol (Noisy-le-grand)2009551667119268004
   PubMed Web of Science ®Google Scholar
• CarsonRWDunniganEJDuBoseTDJrGoegerDEAndersonKERemoval of plasma porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal diseaseJ Am Soc Nephrol199229144514501627767
   PubMed Web of Science ®Google Scholar
• AndersonKEGoegerDECarsonRWLeeSMSteadRBErythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysisN Engl J Med199032253153172104958
   PubMed Web of Science ®Google Scholar
• WarholmCWilczekHRenal transplantation in a case of acute intermittent porphyriaJ Clin Pharmacol200343101158116014517198
   PubMed Web of Science ®Google Scholar
• WahlinSHarperPSardhEAnderssonCAnderssonDEEriczonBGCombined liver and kidney transplantation in acute intermittent porphyriaTransplant Int2010236e18e21
   PubMed Web of Science ®Google Scholar
• ÅbergFJulaAHöckerstedtKIsoniemiHCardiovascular risk profile of patients with acute liver failure after liver transplantation when compared with the general populationTransplantation201089616820061920
   PubMed Web of Science ®Google Scholar
• ÅbergFKoivusaloAMHöckerstedtKIsoniemiHRenal dysfunction in liver transplant patients: comparing patients transplanted for liver tumor or acute or chronic diseaseTranspl Int20072059159917425724
   PubMed Web of Science ®Google Scholar
• ÅbergFPukkalaEHöckerstedtKSankilaRIsoniemiHRisk of malignant neoplasms after liver transplantation: a population-based studyLiver Transpl2008141428143618825704
   PubMed Web of Science ®Google Scholar
• AnderssonCBjersingLLithnerFThe epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyriaJ Int Med19962404195201
   PubMed Web of Science ®Google Scholar
• LithnerFWetterbergLHepatocellular carcinoma in patients with acute intermittent porphyriaActa Med Scand198421532712746328897
   PubMedGoogle Scholar
• KauppinenRMustajokiPAcute hepatic porphyria and hepatocellular carcinomaBr J Cancer19885711171202831925
   PubMed Web of Science ®Google Scholar
• ColomboMSangiovanniATreatment of hepatocellular carcinoma: beyond international guidelinesLiver Int201535Suppl 112913825529098
   PubMed Web of Science ®Google Scholar
• SolisCMartinez-BermejoANaidichTPAcute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyriasArch Neurol200461111764177015534187
   PubMedGoogle Scholar
• LinTCLaiSLHsuSPRoLSTreatment of neuropathic pain in acute intermittent porphyria with gabapentinJ Formos Med Assoc2013112957857923735466
   PubMed Web of Science ®Google Scholar
• JohanssonAMollerCFoghJHarperPBiochemical characterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacementMol Med200399–1219319915208740
   PubMed Web of Science ®Google Scholar
• JohanssonANowakGMollerCBlombergPHarperPAdenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyriaMol Ther200410233734315294180
   PubMed Web of Science ®Google Scholar
• JohanssonAMollerCHarperPCorrection of the biochemical defect in porphobilinogen deaminase deficient cells by non-viral gene deliveryMol Cell Biochem20032501–2657112962144
   PubMed Web of Science ®Google Scholar
• JohanssonAMollerCGellerforsPHarperPNon-viral mediated gene transfer of porphobilinogen deaminase into mammalian cellsScand J Clin Lab Invest200262210511312004925
   PubMed Web of Science ®Google Scholar
• JohanssonANowakGMollerCHarperPNon-viral delivery of the porphobilinogen deaminase cDNA into a mouse model of acute intermittent porphyriaMol Gen Metab20048212026
   Web of Science ®Google Scholar
• TarnerIHMuller-LadnerUFathmanCGTargeted gene therapy: frontiers in the development of ‘smart drugs’Trends Biotechnol200422630431015158060
   PubMed Web of Science ®Google Scholar
• YasudaMBishopDFFowkesMChengSHGanLDesnickRJAAV8-mediated gene therapy prevents induced biochemical attacks of acute intermittent porphyria and improves neuromotor functionMol Ther2010181172219861948
   PubMed Web of Science ®Google Scholar
• PanedaALopez-FrancoEKaeppelCSafety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyriaHum Gene Ther201324121007101724070415
   PubMed Web of Science ®Google Scholar
• Augmenting PBGD expression in the liver as a novel gene therapy for acute intermittent porphyria (AIPgene)Hum Gene Ther Clin Dev2014252616324933563
   PubMed Web of Science ®Google Scholar
• YasudaMGanLChenBRNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria miceProc Natl Acad Sci USA2014111217777778224821812
   PubMed Web of Science ®Google Scholar
• WaldenströmJStudien uber Porphyrie [Studies of porphyria]Acta Med Scand193792Suppl1254 German
   Google Scholar